Tolerability and efficacy of naratriptan tablets in the acute treatment of migraine attacks for 1 year

Cephalalgia

Volumn 20, Issue 5, 2000, Pages 470-474

  Heywood, J ^a   Bomhof, M A M ^b   Pradalier, A ^c   Thaventhiran, L ^d   Winter, P ^d   Hassani, H ^d  

^a AUSTIN HEALTH   (Australia)

^b Ignatius Hospital   (Netherlands)

^c HÔPITAL LOUIS MOURIER   (France)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5HT1 agonist; Migraine; Naratriptan; Safety; Tolerability

Indexed keywords

NARATRIPTAN;

ADULT; ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPOSALIVATION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; SOMNOLENCE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PIPERIDINES; RETREATMENT; SALVAGE THERAPY; SEROTONIN AGONISTS; TABLETS; TIME FACTORS; TRYPTAMINES;

EID: 0034454209     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00066.x     Document Type: Article

References (10)

1. Naratriptan tablets are effective and well-tolerated in the acute treatment of migraine: Results of a double-blind, placebo-controlled, parallel-group trial
2. Efficacy and tolerability of naratriptan tablets in the treatment of migraine: Results of a double-blind, placebo-controlled, crossover trial
3. Randomised, double-blind, placebo-controlled comparison of oral naratriptan and oral sumatriptan in the acute treatment of migraine
4. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
5. The tolerability and efficacy of naratriptan tablets with long-term treatment (6 months)
6. A comparison of the efficacy, safety, and tolerability of naratriptan and sumatriptan
7. Oral sumatriptan: Effect of a second dose, and incidence and treatment of headache recurrences
8. A randomised, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine
9. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine
10. Rizatriptan vs sumatriptan in the acute treatment of migraine: A placebo-controlled, dose-ranging study